GI Permeability Change in Response to Aquamin®
Completed · Phase 2
Conditions studied: Ulcerative Colitis, Healthy, Irritable Bowel Syndrome With Diarrhea
In brief
This trial is being completed to learn about how Aquamin® affects gastrointestinal permeability, or the control of material passing from inside the gastrointestinal tract through the gut wall into the rest of the body, in people with ulcerative colitis (UC), Irritable Bowel Syndrome with diarrhea (IBS-D), and in healthy individuals.
Key facts
- Study ID
- NCT04855799
- Run by
- James Varani
- People needed
- 35
- Starts
- 2021-11-02
- Expected to finish
- 2024-03-25
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- University of Michigan Hospital — Ann Arbor, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.